Company Filing History:
Years Active: 2021
Title: Innovations in Cancer Treatment by Jeff Kremer
Introduction
Jeff Kremer is an accomplished inventor based in St. Louis, MO (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer. His innovative approach focuses on the role of malic enzyme 1 (ME1) in cancer treatment.
Latest Patents
Jeff Kremer holds a patent for "Methods of diagnosing and treating cancer comprising ME1." This patent outlines a method for determining cancer treatment by identifying the absence of malic enzyme 1 and utilizing an inducer of ferroptosis for treatment. He has 1 patent to his name, showcasing his commitment to advancing cancer therapies.
Career Highlights
Kremer is affiliated with Washington University, where he conducts research and develops innovative treatment methods. His work has garnered attention for its potential to improve cancer treatment outcomes. His dedication to research and innovation has positioned him as a key figure in the medical community.
Collaborations
Jeff Kremer collaborates with esteemed colleagues, including Brian Van Tine and Sara S. Lange. These partnerships enhance the research efforts and contribute to the development of effective cancer treatments.
Conclusion
Jeff Kremer's innovative work in cancer treatment exemplifies the impact of research and invention in the medical field. His contributions are paving the way for new therapeutic approaches that could significantly benefit cancer patients.